MTOR and lung carcinoma: From the biomarkers associated with brain metastasis of lung cancer, we discover a significant enrichment of PI3K-pathway aberration and verify using our pharmacogenomic database that targeting MTOR is highly effective in treating lung cancer brain metastasis.